Home

Azenta, Inc. - Common Stock (AZTA)

54.05
+0.14 (0.26%)

Azenta, Inc. is a leading provider of life sciences solutions, focusing on enabling advancements in research and development through its innovative technologies and services

The company specializes in genomic solutions, including sample storage, processing, and logistics, aimed at supporting biobanking and accelerating the discovery of new therapies. With a commitment to enhancing global health, Azenta's offerings cater to the needs of pharmaceutical and biotechnology companies, academic institutions, and research organizations, ultimately striving to improve the efficiency and effectiveness of life sciences research.

SummaryNewsPress ReleasesChartHistoricalFAQ
5 medical stocks growing earnings by triple digits
There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning
Via MarketBeat · February 6, 2024
16 Top Robotics Companies to Get to Know in 2023
What are the top robotics companies in the USA, as robotics continues to grow? Learn more about the best companies today with MarketBeat.
Via MarketBeat · September 11, 2023
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19, 2023. Dr. Nova succeeds Brian Birk, who has served as Chair of the Board of Directors at Exagen since 2018, and who will remain a member of the Board.  
By Exagen Inc. · Via GlobeNewswire · January 23, 2023